Table 3.
Geographical representation in the original studies supporting the 2021 Surviving Sepsis Campaign guidelines based on World Bank classification for regions
| Recommendation | Studies (n) |
East Asia Pacific n (%) |
Europe Central Asia n (%) |
Latin America Caribbean n (%) |
Middle East North Africa n (%) |
North America n (%) |
South Asia n (%) |
Sub-Saharan Africa n (%) |
|---|---|---|---|---|---|---|---|---|
| Screening & Early Treatment | 30* |
2 (7) |
10 (33) |
4 (13) |
1 (3) |
14 (47) |
0 (0) |
4 (13) |
| Infection | 126* |
25 (20) |
55 (44) |
12 (10) |
9 (7) |
54 (43) |
3 (2) |
8 (6) |
| Hemodynamic Management | 47* |
9 (19) |
16 (34) |
1 (2) |
3 (6) |
25 (53) |
0 (0) |
1 (2) |
| Ventilation | 41* |
8 (20) |
27 (66) |
10 (24) |
5 (12) |
19 (46) |
0 (0) |
1 (2) |
| Additional Therapies | 36* |
3 (8) |
19 (53) |
2 (6) |
2 (6) |
13 (36) |
2 (6) |
0 (0) |
|
Long Term Outcomes/ Goals of Care |
83 |
7 (8) |
31 (37) |
0 (0) |
0 (0) |
46 (55) |
0 (0) |
0 (0) |
*Total number of studies is higher than that of the total number of studies from each classification group since some studies were conducted in more than one region